Flagship Harbor Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Flagship Harbor Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.22M	Buy	6,407 +904	+16%	+$155K	0.05%	308
2026 Q1	$929K	Buy	5,503 +1,574	+40%	+$269K	0.04%	329
2025 Q4	$663K	Buy	3,929 +1,990	+103%	+$323K	0.03%	381
2025 Q3	$280K	Buy	+1,939	New	+$265K	0.01%	656
2024 Q4	–	Sell	-2,617	Closed	-$381K	–	759
2024 Q3	$381K	Buy	+2,617	New	+$379K	0.02%	488
2023 Q1	–	Sell	-38,086	Closed	-$5M	–	634
2022 Q4	$5M	Buy	38,086 +35,455	+1,348%	+$4.58M	0.51%	42
2022 Q3	$308K	Buy	2,631 +78	+3%	+$9.69K	0.04%	428
2022 Q2	$300K	Sell	2,553 -365	-13%	-$43.3K	0.03%	457
2022 Q1	$380K	Sell	2,918 -1,372	-32%	-$179K	0.04%	422
2021 Q4	$655K	Sell	4,290 -140	-3%	-$21.7K	0.06%	301
2021 Q3	$725K	Hold	4,430	–	–	0.08%	274
2021 Q2	$725K	Sell	4,430 -1,907	-30%	-$294K	0.08%	275
2021 Q1	$954K	Sell	6,337 -125	-2%	-$19.9K	0.11%	200
2020 Q4	$979K	Buy	6,462 +1,387	+27%	+$198K	0.12%	181
2020 Q3	$687K	Buy	5,075 +1,509	+42%	+$205K	0.09%	209
2020 Q2	$487K	Sell	3,566 -60	-2%	-$7.65K	0.07%	259
2020 Q1	$391K	Sell	3,626 -146	-4%	-$16.8K	0.08%	244
2019 Q4	$455K	Buy	3,772 +3,246	+617%	+$362K	0.08%	247
2019 Q3	$52K	Sell	526 -669	-56%	-$70K	0.01%	770
2019 Q2	$130K	Sell	1,195 -6,219	-84%	-$662K	0.03%	508
2019 Q1	$828K	Sell	7,414 -45	-0.6%	-$4.94K	0.17%	129
2018 Q4	$719K	Sell	7,459 -710	-9%	-$75.4K	0.17%	129
2018 Q3	$990K	Buy	8,169 +968	+13%	+$114K	0.18%	129
2018 Q2	$790K	Buy	7,201 +132	+2%	+$14.1K	0.16%	143
2018 Q1	$726K	Buy	7,069 +449	+7%	+$49.8K	0.22%	120
2017 Q4	$716K	Buy	6,620 +191	+3%	+$20.4K	0.21%	126
2017 Q3	$726K	Buy	6,429 +822	+15%	+$87.9K	0.24%	112
2017 Q2	$580K	Buy	5,607 +462	+9%	+$45.5K	0.2%	140
2017 Q1	$491K	Buy	5,145 +618	+14%	+$59.2K	0.19%	146
2016 Q4	$411K	Buy	+4,527	New	+$412K	0.18%	151

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Flagship Harbor Advisors's IBB Position: Q2 2026 in Review

Flagship Harbor Advisors increased its iShares Biotechnology ETF (IBB) stake by 16% in Q2 2026, buying an estimated $155K and bringing the position to 6,407 shares worth $1.22M. The position accounts for 0.05% of the portfolio, ranked #308.

Flagship Harbor Advisors first reported a position in IBB in Q4 2016 and has held it in 30 quarters since. The position peaked at $5M in Q4 2022. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Flagship Harbor Advisors held 6,407 shares of iShares Biotechnology ETF worth $1.22M as of Q2 2026.
Flagship Harbor Advisors bought 904 iShares Biotechnology ETF shares in Q2 2026, an estimated $155K.
iShares Biotechnology ETF made up 0.05% of Flagship Harbor Advisors's portfolio in Q2 2026, its #308 holding.
Flagship Harbor Advisors first reported a position in iShares Biotechnology ETF in Q4 2016 and has held it in 30 quarters since.
Flagship Harbor Advisors's iShares Biotechnology ETF position peaked at $5M in Q4 2022.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Flagship Harbor Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.